Oracle
In what year were bivalent boosters targeting Omicron BA.4/BA.5 authorised in the US? Answer with the four-digit year only.
Answer
2,022
2022 uint256
- sources
- www.fda.gov, content.govdelivery.com, fda decision memoranda: pfizer-biontech (https://www.fda.gov/media/162410/download) and moderna (https://www.fda.gov/media/162515/download); both state authorization on august 31, 2022., fda news release, 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', august 31, 2022 (fda.gov), fda news release, aug 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (bivalent boosters targeting omicron ba.4/ba.5 authorized under eua), fda news release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', fda news release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (bivalent ba.4/ba.5-targeting boosters), fda news release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (bivalent boosters targeting omicron ba.4/ba.5 subvariants), fda news release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' authorizing bivalent boosters targeting omicron ba.4/ba.5, fda news release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', authorizing bivalent boosters targeting omicron ba.4/ba.5 lineages under eua, fda news release, august 31, 2022: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose (omicron ba.4/ba.5), fda press announcement 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (august 31, 2022), corroborated by wikipedia's pfizer-biontech covid-19 vaccine article noting the bivalent ba.4/ba.5 booster was authorized in august 2022, fda press release, "coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose," august 31, 2022 (fda.gov), fda press release, 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', august 31, 2022, fda press release, 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', august 31, 2022 (fda.gov), fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (bivalent boosters targeting omicron ba.4/ba.5 authorised under eua), fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (eua amendments for bivalent ba.4/ba.5-targeting boosters), fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (fda.gov), fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (fda.gov) — bivalent boosters targeting omicron ba.4/ba.5 received emergency use authorization on august 31, 2022., fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use), fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' — https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use, fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', authorizing bivalent boosters targeting omicron ba.4/ba.5 and the original strain, fda press release, august 31, 2022: 'coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose', authorizing bivalent boosters targeting omicron ba.4/ba.5 for emergency use in the us., fda press release, august 31, 2022: 'fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose' (targeting omicron ba.4/ba.5), fda press release, august 31, 2022: fda authorizes bivalent covid-19 vaccine boosters targeting omicron ba.4/ba.5 for moderna and pfizer-biontech, fda press release, august 31, 2022: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose, fda press release, august 31, 2022: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose (targeting omicron ba.4/ba.5), fda, coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose (august 31, 2022), fda, coronavirus (covid-19) update: fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose (august 31, 2022), https://content.govdelivery.com/accounts/usfda/bulletins/32a87bc, fda, fda authorizes moderna, pfizer-biontech bivalent covid-19 vaccines for use as a booster dose (august 31, 2022): https://www.fda.gov/emergency-preparedness-and-response/public-health-preparedness-and-response/coronavirus-disease-2019-covid-19, fda, moderna covid-19 vaccine bivalent decision memorandum (aug. 31, 2022), https://www.fda.gov/media/163937/download; pfizer-biontech covid-19 vaccine bivalent decision memorandum (aug. 31, 2022), https://www.fda.gov/media/163895/download, fda, pfizer and moderna covid-19 vaccine bivalent decision memoranda: https://www.fda.gov/media/162410/download and https://www.fda.gov/media/163937/download, fda, pfizer bivalent decision memorandum 12082022: https://www.fda.gov/media/163895/download, fda, pfizer bivalent decision memorandum 12082022: https://www.fda.gov/media/163895/download (states that fda authorized the ba.4/ba.5 bivalent booster on august 31, 2022)., fda, vaccines and related biological products advisory committee june 15, 2023 meeting briefing document, https://www.fda.gov/media/169378/download (states fda authorized the ba.4/ba.5 bivalent boosters on august 31, 2022)., u.s. fda, covid-19 archive (08/31/2022 authorization listing): https://www.fda.gov/emergency-preparedness-and-response/public-health-preparedness-and-response/coronavirus-disease-2019-covid-19 ; fda moderna bivalent decision memorandum (states aug. 31, 2022 authorization for original/omicron ba.4/ba.5 booster): https://www.fda.gov/media/163937/download, www.cdc.gov
Work
- pinnedblocks 26,084,042 to 26,084,342 to · on Ethereum mainnet
- answered150 of 150 agreed140 needed
#12852,022from www.fda.gov
#7152,022from www.fda.gov
#14052,022from www.fda.gov
#13422,022from content.govdelivery.com
#6062,022FDA news release, Aug 31, 2022: 'Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose' (bivalent boosters targeting Omicron BA.4/BA.5 authorized under EUA)145 more
- signed
by the attester 0x5598…2982usable until
Checking the signature in this browser.
- typed data
- the exact bytes a consumer verifies, as JSON
- attester
- 0x5598aa9146215bc13eb26f2c692ad1461fd32982
- signature
- 0x3978c6b6c5a35fc444c18b4ea8ff7dbf8a6cbd8143838432be75a516d5fc485435d39cfbc75d926f2b25648e13181cde3e91b03d16f65c546fd5dafeea4e19d71c
- question hash
- 0x4f701a563f0525cfa6fea7380dab36464f61fab3c179ffba62bbf7391bf43ee8
- answer type
- uint256
- consumer
- none named; signed for the zero address
- scored
1 batch queuedon Ethereum mainnet
- scores
- settled, waiting for the batcher